The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

Autor: Arvin M. Gouw, Aida S. Hansen, Wadie D. Mahauad-Fernandez, Renumathy Dhanasekaran, Anja Deutzmann, Dean W. Felsher
Rok vydání: 2021
Předmět:
Zdroj: Nat Rev Clin Oncol
ISSN: 1759-4782
1759-4774
DOI: 10.1038/s41571-021-00549-2
Popis: The MYC proto-oncogenes encode a family of transcription factors that are among the most commonly activated oncoproteins in human neoplasias. Indeed, MYC aberrations or upregulation of MYC-related pathways by alternate mechanisms occur in the vast majority of cancers. MYC proteins are master regulators of cellular programmes. Thus, cancers with MYC activation elicit many of the hallmarks of cancer required for autonomous neoplastic growth. In preclinical models, MYC inactivation can result in sustained tumour regression, a phenomenon that has been attributed to oncogene addiction. Many therapeutic agents that directly target MYC are under development; however, to date, their clinical efficacy remains to be demonstrated. In the past few years, studies have demonstrated that MYC signalling can enable tumour cells to dysregulate their microenvironment and evade the host immune response. Herein, we discuss how MYC pathways not only dictate cancer cell pathophysiology but also suppress the host immune response against that cancer. We also propose that therapies targeting the MYC pathway will be key to reversing cancerous growth and restoring antitumour immune responses in patients with MYC-driven cancers.
Databáze: OpenAIRE
Externí odkaz: